TY - JOUR
T1 - Pharmacogenomics education in medical and pharmacy schools
T2 - Conclusions of a global survey
AU - Karas Kuželički, Nataša
AU - Prodan Žitnik, Irena
AU - Gurwitz, David
AU - Llerena, Adrian
AU - Cascorbi, Ingolf
AU - Siest, Sofia
AU - Simmaco, Maurizio
AU - Ansari, Marc
AU - Pazzagli, Mario
AU - DI Resta, Chiara
AU - Brandslund, Ivan
AU - Schwab, Matthias
AU - Vermeersch, Pieter
AU - Lunshof, Jeantine E.
AU - Dedoussis, George
AU - Flordellis, Christodoulos S.
AU - Fuhr, Uwe
AU - Stingl, Julia C.
AU - Van Schaik, Ron H.N.
AU - Manolopoulos, Vangelis G.
AU - Marc, Janja
N1 - Publisher Copyright:
© 2019 Future Medicine Ltd.
PY - 2019
Y1 - 2019
N2 - Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim was to evaluate the progress in pharmacogenomics education since then, and to put forward further recommendations. Methods: A survey was sent to 248 schools of medicine, pharmacy, nursing and health professions around the world. Results: The majority of the study programs (87%) include pharmacogenomics education, which is generally taught as part of the pharmacology curriculum. On average, educators and teachers have selected appropriate and highly relevant pharmacogenomics biomarkers to include in their teaching programs. Conclusions: Based on the results, we can conclude that the state of pharmacogenomics education at the surveyed universities has improved substantially since 2005.
AB - Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim was to evaluate the progress in pharmacogenomics education since then, and to put forward further recommendations. Methods: A survey was sent to 248 schools of medicine, pharmacy, nursing and health professions around the world. Results: The majority of the study programs (87%) include pharmacogenomics education, which is generally taught as part of the pharmacology curriculum. On average, educators and teachers have selected appropriate and highly relevant pharmacogenomics biomarkers to include in their teaching programs. Conclusions: Based on the results, we can conclude that the state of pharmacogenomics education at the surveyed universities has improved substantially since 2005.
KW - education
KW - global survey
KW - medicine
KW - pharmacogenomics
KW - pharmacy
KW - recommendations
UR - http://www.scopus.com/inward/record.url?scp=85068128288&partnerID=8YFLogxK
U2 - 10.2217/pgs-2019-0009
DO - 10.2217/pgs-2019-0009
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85068128288
SN - 1462-2416
VL - 20
SP - 643
EP - 657
JO - Pharmacogenomics
JF - Pharmacogenomics
IS - 9
ER -